Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis.

  “Endocannabinoids contribute to hemodynamic abnormalities of cirrhosis. Whether this favors renal sodium retention and ascites formation is unknown. We determined whether cannabinoid type 1 receptor antagonism prevents sodium retention and ascites formation in preascitic cirrhotic rats.”

 

“Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis.”

 

“Rimonabant improves sodium balance and delays decompensation in preascitic cirrhosis. This is achieved though an improvement in systemic and renal hemodynamics, although it cannot be excluded that the antifibrotic effect of the drug may play a role.”

http://www.ncbi.nlm.nih.gov/pubmed/19208344